Abstract. Tumor microenvironments play critical regulatory roles in tumor growth. Although mouse cancer models have contributed to the understanding of human tumor biology, the effectiveness of mouse cancer models is limited by the inability of the models to accurately present humanized tumor microenvironments. Previously, a humanized breast cancer model in severe combined immunodeficiency mice was established, in which human breast cancer tissue was implanted subcutaneously, followed by injection of human breast cancer cells. It was demonstrated that breast cancer cells showed improved growth in the human mammary microenvironment compared with a conventional subcutaneous mouse model. In the present study, the novel mouse model and microarray technology was used to analyze changes in the expression of genes in breast cancer cells that are regulated by the human mammary microenvironment. Humanized breast and conventional subcutaneous mouse models were established, and orthotopic tumor cells were obtained from orthotopic tumor masses by primary culture. An expression microarray using Illumina HumanHT-12 v4 Expression BeadChip and database analyses were performed to investigate changes in gene expression between tumors from each microenvironment. A total of 94 genes were differentially expressed between the primary cells cultured from the humanized and conventional mouse models. Significant upregulation of genes that promote cell proliferation and metastasis or inhibit apoptosis, such as SH3-domain binding protein 5 (BTK-associated), sodium/chloride cotransporter 3 and periostin, osteoblast specific factor, and genes that promote angiogenesis, such as KIAA1618, was also noted. Other genes that restrain cell proliferation and accelerate cell apoptosis, including tripartite motif containing TRIM36 and NES1, were downregulated. The present results revealed differences in various aspects of tumor growth and metabolism between the two model groups and indicated the functional changes specific to the human mammary microenvironment.
Introduction
Over previous years, tumor microenvironments have been recognized to play important roles in regulating tumor progression (1) . The tumor microenvironment includes interwoven stroma and cells, such as fibroblasts, adipocytes, myoepithelial cells, inflammatory cells and endothelial cells, in addition to the secreted factors of the stroma and cells. The tumor microenvironment promotes tumor growth, stimulates angiogenesis, increases inflammatory response and induces metastasis (1) (2) (3) (4) .
Mouse models of human cancer play a crucial role in cancer research and the screening of anticancer agents (5, 6) . However, although certain agents show consistent and potent anticancer activity in mouse models, the response rate among patients in phase I clinical trials is <10% (7, 8) . Therefore, it has been hypothesized that current mouse models cannot accurately mimic the humanized tumor microenvironment (9) .
Previously, a humanized mouse model of breast cancer, in which normal human breast tissue was implanted under the sub-dermis of mice, was developed. Human breast cancer cell lines were then injected into the implants (10) . Compared with the conventional subcutaneous (SUB) mouse model, in which human breast cancer cells are directly injected under the subdermis, this novel human breast tissue-derived (HB) mouse model was hypothesized to more accurately mimic the interactions between the human mammary microenvironment and human breast cancer cells (11) . To obtain detailed characterization of this model, tumor formation and metastasis were compared between the HB and SUB mouse models (3) . Orthotopic tumor cells were obtained from orthotopic tumor masses of these two models by primary culture and evaluated in in vitro experiments. In vivo, cellular and molecular experiments compared the biology of human breast cancer cells. It was confirmed that human breast cancer cells demonstrated better growth in the human mammary microenvironment compared with the mouse subcutaneous microenvironment. As expected, the human-specific microenvironment more accurately regulates the proliferation and metastasis of human breast cancer cells (12) . These initial findings prompted the investigation of the mechanisms underlying the regulatory genes and pathways specific to the human mammary microenvironment.
Screening and analysis of breast
In the present study, the HB and SUB mouse models were established, and orthotopic tumor cells were obtained from orthotopic tumor masses by primary culture. Gene expression profiles were evaluated by microarray to screen altered gene expression in the primary breast cancer cells that were regulated by the human mammary microenvironment and subcutaneous microenvironment. Furthermore, differentially expressed genes were validated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and analyzed using several databases.
Materials and methods
Cell culture. The human breast cancer SUM1315 cell line was provided by Dr Stephen Ethier (University of Michigan, Ann Arbor, MI, USA) were labeled with green fluorescent protein (GFP), as previously described (13) . GFP-labeled SUM1315 cells (G1315) were cultured in Gibco Dulbecco's modified Eagle's medium (DMEM; Thermo Fisher Scientific, Inc.) supplemented with 10% Gibco fetal bovine serum (FBS; Thermo Fisher Scientific, Inc.) and 1% penicillin-streptomycin solution (Gibco; Thermo Fisher Scientific, Inc.) in a humidified atmosphere of 5% CO 2 at 37˚C.
Animals.
Female severe combined immunodeficiency (SCID) CB-17IcrCrl-scidbgBR mice aged 4-6 weeks were purchased from the Model Animal Research Center of Nanjing University (Nanjing, Jiangsu, China). The SCID mice were kept under specific pathogen-free, temperature-controlled conditions. Cages, bedding and drinking water were autoclaved and changed regularly. Food was sterilized by irradiation. The mice were maintained in a daily cycle of 12 h period of lightness and darkness. In total, 6 mice were randomly divided into two groups to establish the HB and SUB mouse models.
Development of the humanized HB models. Normal human breast tissues were obtained in May 2013 from elective breast reduction mammoplasty surgery of 3 patients at the The First Affliated Hospital of Nanjing Medical University (Nanjing, Jiangsu, China). Sample collection was performed in accordance with the ethical guidelines of the Declaration of Helsinki (14) , and approved by the Ethics and Research Committee of the First Affiliated Hospital with Nanjing Medical University (Nanjing, Jiangsu, China). Breast tissues were sliced under sterile conditions into pieces ~4x4x4 mm in size. Three pieces were selected randomly for histological examination to exclude primary malignant disease. Small pieces of the human breast tissues were placed in ice-cold PBS until implantation into SCID mice. Implantation was finished within 6 h of mammoplasty surgery. Prior to implantation, the mice were anesthetized by intraperitoneal injection with 1% pentobarbital sodium (10 µl/g body weight; Sigma-Aldrich, Steinheim, Germany). Surgical procedures were modified from a previous method (15) , which transplanted human gastric tissue, whereas in the present study, human mammary tissue was transplanted. Briefly, 5-6-mm scalpel incisions were made in the skin of the left mid-dorsal flank of mice, through which 5 human breast tissue fragments were implanted subcutaneously. The mice received gentamycin in the drinking water (800,000 U/l) until 1 week following the implantation. All in vivo experiments were conducted according to the Guide for the Care and Use of Laboratory Animals (16) and approved by the Animal Care and Use Committee of Nanjing Medical University.
Injection of human breast cancer cells into SCID mice.
Human breast cancer cells (~80% confluent) were cultured in fresh DMEM supplemented with 10% FBS and 1% penicillin-streptomycin solution for 24 h. The cells were harvested with 0.25% tyrosine and 0.02% disodium EDTA (Gibco; Thermo Fisher Scientific, Inc.), washed in medium, counted, and re-suspended in PBS. Human breast cancer cells (5x10 5 ) in 0.2 ml PBS were injected into the implanted human breast tissues ~1 week subsequent to implantation of the human breast tissue. Equal amounts of tumor cells were injected into the left mid-dorsal flank subcutaneously to form the SUB control group.
Primary cultured tumor cells. All mice were sacrificed 5 weeks subsequent to injection of human breast cancer cells. Orthotopic tumor masses were collected under sterile conditions. One section was used for histological examination and another section was used for primary culture. Primary culture was conducted as previously described (13) . Briefly, sections of the orthotopic tumor masses (2x2x2 mm) were washed in sterile PBS with 1% penicillin-streptomycin three times, and broken into small tumor pieces using scissors (1-2 Hz for 10 min) in 0.2 ml PBS. PBS (3 ml) was then added to the mixture, and the samples were centrifuged at 129 x g for 5 min in a centrifuge (Eppendorf, Hamburg, Germany). Subsequent to discarding the supernatant, the sedimentary tumor pieces were re-suspended in 5 ml DMEM and transferred to 10 cm dishes. Another 10 ml DMEM was added into the dishes for routine cell culture 16 h later. Following 5-7 days of culture, breast cancer cells from small tumor pieces adhered to dishes and the small tumor pieces were discarded. GFP-labeled primary cultured tumor cells were grown to ~80% confluency and harvested for fluorescence activated cell sorting (FACS) 1 week later. FACS analysis was conducted according to the manufacturer's protocol (FACSCalibur; BD Biosciences, Franklin Lakes, NJ, USA). The primary cultured human breast cancer cells were finally obtained, as follows: primary cultured G1315 cells from HB mouse models (pri-HB-1315); and primary cultured G1315 cells from SUB mouse models (pri-SUB-1315).
Total RNA extraction. Total RNA was isolated from primary cells using TRIzol ® reagent (Thermo Fisher Scientific, Inc.) combined with the Qiagen RNeasy Lipid Tissue kit protocol (Qiagen, Valencia, CA, USA), according to the manufacturer's recommendation. RNA concentrations and the A260 nm/A280 nm ratio were assessed using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Inc., Waltham, MA, USA).
Microarray expression analysis. The HumanHT-12 v4 expression microarray (Illumina, Inc., San Diego, CA, USA) platform was used to measure expression levels in each unpooled specimen, according to the manufacturer's instructions. Briefly, subsequent to purification of RNA using an RNeasy Mini kit, 500 ng of total RNA was amplified and biotin-labeled with the Ambion Illumina ® Total Prep RNA Amplification kit (Thermo Fisher Scientific, Inc.). Labeled cRNAs were hybridized to the Illumina HumanHT-12 V4 expression BeadChip (Illumina, Inc.) and imaged using an Iscan system. Raw data was obtained using GenomeStudio Software (Illumina, Inc.).
RT-qPCR. RT-qPCR was used to verify the gene expression profile results. In total, 10 target genes were selected. PCR for the reference gene β-actin and target genes was performed for each cDNA sample, as in the microarray. All PCR reactions were performed on the Eppendorf MasterCycler RealPlex (Eppendorf) using the fluorescent SYBR Green I methodology with SYBR ® Premix Ex Taq™ (Takara, Dalian, Liaoning, China), according to the manufacturer's instructions. The thermal cycling conditions consisted of 10 min at 95˚C and 40 cycles of 10 sec denaturation at 95˚C, 15 sec annealing at 58˚C, and 45 sec extension at 72˚C. The primer sequences for RT-qPCR are listed in Table Ⅰ . The mRNA quantities were analyzed in triplicate and normalized against β-actin as a control gene. The results are expressed as relative gene expression using the 2 -ΔΔCq method (17) .
Statistical analysis. All data were analyzed using the SPSS software, version 12.0 (SPSS, Chicago, IL, USA). Paired t-test was used to screen differential genes in the microarray. Student's t-test was used for the analysis of the qPCR results. P<0.05 was considered to indicate a statistically significant difference.
Results

Global changes in gene expression.
A total of 94 genes were differentially expressed in the pri-HB-1315 cells cultured from the HB model and the pri-SUB-1315 cells cultured from the SUB model (Table Ⅱ) . Gene ontology (GO) analysis (18, 19) was applied to obtain insight into the biology associated with the stereotypic differences between the pri-HB-1315 and pri-SUB-1315 cells. Significant enrichment of 16 molecular functions, 6 distinct biological processes and 2 cellular Table IV) .
RT-qPCR.
A total of 10 genes were selected based upon microarray data and biological significance. Consistent with the microarray results, RT-qPCR confirmed the differential expression of 8 genes, with only 2 genes not demonstrating differential expression (Table Ⅴ) . Genes with significantly increased expression in the pri-HB-1315 group included SH3-domain binding protein 5 (BTK-associated), ribosomal protein L32 (RPL32), B-cell CLL/lymphoma 10 (BCL10), leucine-rich repeats and transmembrane domains 1 and KIAA1618 (P<0.05), while bromodomain PHD finger transcription factor (BPTF), tripartite motif containing 36 (TRIM36) and fibroblast growth factor 13 expression was significantly decreased in the pri-HB-1315 group (P<0.05). The other 2 genes, coiled-coil domain containing 113 and PWWP domain containing 2A, showed no significant difference in expression between the two groups.
Discussion
Several studies have examined the expression of genes in breast cancer cells co-cultured with stroma cells in in vitro models (21) (22) (23) (24) . However, in vitro models do not fully recapitulate all dynamics and dimensions of the tissue, and a complete picture of stromal-epithelial interactions requires linkages with studies in vivo. A novel mouse model that was implanted with human mammary tissue was previously established (10). As an in vivo model, it provides a humanized microenvironment and was shown to be more accurate than the conventional subcutaneous mouse model in mimicking human breast cancer cells and the human mammary microenvironment (12) . In the present study, the novel mouse model and microarray technology was used to analyze the gene expression changes in breast cancer cells regulated by the human mammary microenvironment. The expression levels of 94 identified genes were modulated by the human mammary microenvironment. Out of the 94 genes, several genes that promoted cell proliferation and metastasis or inhibited apoptosis were upregulated in the pri-HB-1315 group, including SH3BP5 (25), sodium/chloride cotransporter 3 (26, 27) and periostin, osteoblast specific factor (28, 29) . Other genes that restrain cell proliferation and accelerate cell apoptosis were downregulated in the pri-HB-1315 group, such as TRIM36 (30) and NES1 (31) . In addition, genes that promote angiogenesis were upregulated, including KIAA1618 (32) . RPL32 is a protein component of ribosomes, which are sites of protein synthesis (33) . Increased expression of the RPL32 gene indirectly reflects the increased cell proliferation. Alterations in the expression of the aforementioned genes jointly induced and promoted the development of tumors in the pri-HB-1315 group with human mammary microenvironment. However, the upregulation of BCL10 (34) and the downregulation of BPTF (35) in the pri-HB-1315 group appear to correspond with the suppression of tumor progression. In addition, the function of certain genes, such as LTBP2 (36, 37) and RNA binding motif (RNP1, RRM) protein 3 (38, 39) , remains controversial. Notably, certain genes, including angiotensin I converting enzyme 2 (40), which functions in cardiovascular disease, have been demonstrated to play Table Ⅴ . RT-qPCR and microarray results of tested genes compared between pri-HB-1315 and pri-SUB-1315 cells.
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Microarray important roles in other pathophysiological processes (41), but not tumor progression. In future studies, the putative function of these genes in tumor development and their upstream ligand factors in the human mammary microenvironment may be explored. The mapping of genes to GO nodes is a powerful functional genomics tool suited to the analysis of microarray data, as it may be identified whether associated groups of genes from expression clustering share significant functional annotation in the GO database. As shown in Table II , the significantly enriched functional processes were summarized according to biological process, molecular function and cellular components. These changes indicated the existence of pathological processes globally induced by the human mammary microenvironment. The term definition and details were acquired from the GO network (42) . Out of the 16 results of the GO analyses associated with molecular functions, several genes catalyze various reactions and promote cell metabolism, including c-Jun N-terminal kinase activity, mitogen-activated protein kinase activity and protein serine/threonine kinase activity. GOs which are expressed differently between two types of cells are termed 'enriched'. Other enriched GO analysis results involved protein interactions to initiate a change in cell activity, such as dopamine receptor activity. The large ribosomal subunit cellular component was upregulated, and plays an important role in protein synthesis. Furthermore, the epithelial cell proliferation biological process was significantly enriched, and is an important component in breast cancer. The GO analysis revealed differences in various aspects of tumor growth and metabolism between the two model groups and indicated the functional changes specific to the human mammary microenvironment.
In the present humanized HB mouse model, immunodeficient mice were used to ensure improved survival of implanted human breast tissues. One limitation to this model is that this mouse model may include a microenvironment without an immune system. However, the mouse immune system is distinct from the human immune system, and immunodeficient mice have acted as a good platform for implanting a human immune system (43) (44) (45) . Certain efforts have already been made in implanting human immune tissues or cells into immunodeficient mouse models (43) (44) (45) . Indeed, since the implanted human breast tissues cannot survive physically in the mouse body as in the human body, the HB mouse model is not able to absolutely mimic all the species-specific interactions between human breast cancer cells and the human mammary microenvironment. In addition, future studies may be performed using more cell lines and clinical specimens.
In conclusion, the present study screened and analyzed breast cancer gene expression regulated by the human mammary microenvironment based on a novel human breast mouse model. The various regulated genes showed that the species-specific mammary microenvironment of human origin regulated the gene expression of human breast cancer cells. In future studies, the putative function of these genes in tumor development and the upstream and downstream factors of these genes in the human mammary microenvironment may be explored.
